Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Myrexis Inc (MYRX)

Myrexis Inc (MYRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Myrexis Inc C/O XSTELOS HOLDINGS INC. 630 FIFTH AVENUE SUITE 2260 NEW YORK NY 10020 USA

www.myrexis.com P: 801-214-7800

Sector:

Medical

INDUSTRY GROUPING:

Medical - Biomedical

Description:

Myrexis, Inc., formerly known as Myriad Pharmaceuticals, Inc., is a biotechnology company focused on discovering, developing, and commercializing novel therapies for the treatment of cancer. The Company's product pipeline includes Azixa (verubulin, MPC-6827), a microtubule destabilizer for brain cancer; MPC-3100, an HSP90 inhibitor for cancer; MPC-9528, a Cancer Metabolism Inhibitor; MPI-485520, an IKK inhibitor for cancer and inflammation; and others. Myriad Pharmaceuticals, Inc. is based in Salt Lake City, Utah.

Key Statistics

Overview:

Market Capitalization, $K 0
Enterprise Value, $K 0
Shares Outstanding, K 0
Annual Sales, $ 0 K
Annual Net Income, $ -11,620 K
EBIT, $ 0 K
EBITDA, $ 0 K
60-Month Beta 3.86
% of Insider Shareholders 0.01%
% of Institutional Shareholders 0.00%
Float, K 0
% Float 0.00%
Short Interest 1
Short Float 0.00%
Short Volume Ratio 1.00

Growth:

1-Year Return -94.29%
3-Year Return -99.25%
5-Year Return -98.67%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Next Earnings Date 01/01/70
Earnings Per Share ttm 0.00
Annual Dividend & Yield 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Most Recent Dividend 2.860 on 02/19/13
Dividend Payable Date 02/15/13
Dividend Payout Ratio 0.00%

MYRX Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % 0.00%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share 0.00
Interest Coverage 0.00
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar